These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 15330332
1. In-vitro activity of fusidic acid against methicillin-resistant Staphylococcus aureus. Erdenizmenli M, Yapar N, Sengönül A, Yüce A, Cakir N, Yulug N. J Chemother; 2004 Jun; 16(3):310-1. PubMed ID: 15330332 [No Abstract] [Full Text] [Related]
2. Fusidic acid as a potential antistaphylococcal agent. Nicholson J, Chew T, Smith S. N Z Med J; 1999 Jul 09; 112(1091):261-2. PubMed ID: 10448991 [No Abstract] [Full Text] [Related]
3. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin. Lemaire S, Van Bambeke F, Pierard D, Appelbaum PC, Tulkens PM. Clin Infect Dis; 2011 Jun 09; 52 Suppl 7():S493-503. PubMed ID: 21546626 [Abstract] [Full Text] [Related]
4. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections]. Reynaud AE, Espaze EP, Coste-Burel M, Richet H. Pathol Biol (Paris); 1992 May 09; 40(5):466-70. PubMed ID: 1495828 [Abstract] [Full Text] [Related]
5. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole]. Memikoğlu KO, Bayar B, Kurt O, Cokça F. Mikrobiyol Bul; 2002 Apr 09; 36(2):141-5. PubMed ID: 12652865 [Abstract] [Full Text] [Related]
6. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data. Rennie RP. J Cutan Med Surg; 2006 Apr 09; 10(6):277-80. PubMed ID: 17241597 [Abstract] [Full Text] [Related]
9. Fusidic acid resistance in Staphylococcus aureus isolates. Brown EM, Thomas P. Lancet; 2002 Mar 02; 359(9308):803. PubMed ID: 11888633 [No Abstract] [Full Text] [Related]
14. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. Norazah A, Lim VK, Rohani MY, Kamel AG. Med J Malaysia; 2005 Oct 01; 60(4):411-5. PubMed ID: 16570701 [Abstract] [Full Text] [Related]
16. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis]. Peeters KA, Mascini EM, Blok HE, Sanders CJ. Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2100-1. PubMed ID: 12448968 [Abstract] [Full Text] [Related]
19. [Nasal carriage of Staphylococcus aureus in hospital personnel and the normal population and antibiotic resistance of the isolates]. Yazgi H, Ertek M, Ozbek A, Kadanali A. Mikrobiyol Bul; 2003 Nov 02; 37(2-3):137-42. PubMed ID: 14593895 [Abstract] [Full Text] [Related]